Company intelligence / Profile preview

SA Group

Biasca, Ticino, Switzerland

Ownership: Private
Employees: ~200
Development stage: Other

Overview

HAS Healthcare Advanced Synthesis (HAS Group) is a Swiss-based contract development and manufacturing organization (CDMO) specializing in the production of high-value pharmaceutical products. Formed through the integration of HAS and Cerbios, the company focuses on high-potency active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates (ADCs). HAS Group provides end-to-end services ranging from early-stage development and clinical supply to commercial-scale manufacturing. The company is currently undergoing a significant multi-year investment program to expand its ADC conjugation and linker-payload capabilities at its facilities in Biasca and Lugano.

Modalities: Small moleculeAntibody-drug conjugateHigh-potency active pharmaceutical ingredients (HPAPI)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on SA Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SA Group.

Explore the full profile